SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2b8e'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_B_9CRB600_2
(RETINOIC ACID
RECEPTOR, BETA)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
3 / 3 LEU A 429
PHE A 423
ARG A 652
None
0.88A 1xdkB-2b8eA:
undetectable
1xdkB-2b8eA:
23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BR4_E_SAME301_0
(CEPHALOSPORIN
HYDROXYLASE CMCI)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A 429
GLY A 617
ASP A 647
ASP A 424
ALA A 629
None
1.07A 2br4E-2b8eA:
2.6
2br4E-2b8eA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4L_A_TPVA403_1
(PROTEASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A 631
ASP A 424
ILE A 571
GLY A 569
VAL A 568
None
1.21A 2o4lA-2b8eA:
undetectable
2o4lA-2b8eA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OXT_B_SAMB300_0
(NUCLEOSIDE-2'-O-METH
YLTRANSFERASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
6 / 12 GLY A 646
GLY A 617
GLY A 619
THR A 428
LEU A 429
VAL A 658
None
1.00A 2oxtB-2b8eA:
undetectable
2oxtB-2b8eA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C6G_A_VD3A701_2
(CYTOCHROME P450 2R1)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
3 / 3 MET A 506
VAL A 532
GLU A 491
None
0.86A 3c6gA-2b8eA:
undetectable
3c6gA-2b8eA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DH0_A_SAMA220_0
(SAM DEPENDENT
METHYLTRANSFERASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 VAL A 616
GLY A 617
GLY A 619
THR A 428
LEU A 655
None
0.91A 3dh0A-2b8eA:
3.5
3dh0A-2b8eA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EQM_A_ASDA601_1
(CYTOCHROME P450 19A1)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 10 ILE A 571
ASP A 424
THR A 428
VAL A 635
LEU A 626
None
1.28A 3eqmA-2b8eA:
0.0
3eqmA-2b8eA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JW3_B_TOPB208_1
(DIHYDROFOLATE
REDUCTASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 9 ALA A 557
VAL A 421
ILE A 648
LEU A 631
ILE A 662
None
1.12A 3jw3B-2b8eA:
undetectable
3jw3B-2b8eA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S79_A_ASDA601_1
(CYTOCHROME P450 19A1)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 ILE A 571
ASP A 424
THR A 428
VAL A 635
LEU A 626
None
1.28A 3s79A-2b8eA:
undetectable
3s79A-2b8eA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GH8_A_MTXA201_2
(DIHYDROFOLATE
REDUCTASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
3 / 3 LYS A 529
ILE A 464
THR A 572
None
0.88A 4gh8A-2b8eA:
undetectable
4gh8A-2b8eA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IIZ_A_LURA201_1
(TRANSTHYRETIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
3 / 3 LYS A 567
LEU A 590
ALA A 420
None
0.60A 4iizA-2b8eA:
undetectable
4iizA-2b8eA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IK6_A_LURA201_1
(TRANSTHYRETIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
4 / 4 LYS A 567
LEU A 590
ALA A 420
VAL A 612
None
1.23A 4ik6A-2b8eA:
0.0
4ik6A-2b8eA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JEC_B_478B401_3
(HIV-1 PROTEASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
3 / 3 ASP A 496
LEU A 452
VAL A 469
None
0.69A 4jecB-2b8eA:
undetectable
4jecB-2b8eA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KQ8_A_ASDA602_1
(CYTOCHROME P450 19A1)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 10 ILE A 571
ASP A 424
THR A 428
VAL A 635
LEU A 626
None
1.36A 4kq8A-2b8eA:
0.0
4kq8A-2b8eA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LL3_A_017A201_1
(PROTEASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 8 ALA A 531
ASP A 438
VAL A 440
VAL A 517
ILE A 543
None
1.35A 4ll3A-2b8eA:
undetectable
4ll3A-2b8eA:
14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_D_MXMD606_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 VAL A 658
ILE A 566
VAL A 568
LEU A 588
LEU A 561
None
1.47A 4m11D-2b8eA:
undetectable
4m11D-2b8eA:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_C_IPHC101_0
(INSULIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 11 LEU A 429
LEU A 655
ALA A 554
LEU A 586
VAL A 421
None
1.12A 4p65C-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65J-2b8eA:
undetectable
4p65L-2b8eA:
undetectable
4p65C-2b8eA:
8.70
4p65D-2b8eA:
8.13
4p65J-2b8eA:
8.13
4p65L-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_C_IPHC101_0
(INSULIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 11 LEU A 655
ALA A 554
LEU A 586
VAL A 421
LEU A 561
None
0.96A 4p65C-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65J-2b8eA:
undetectable
4p65L-2b8eA:
undetectable
4p65C-2b8eA:
8.70
4p65D-2b8eA:
8.13
4p65J-2b8eA:
8.13
4p65L-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_G_IPHG101_0
(INSULIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 11 LEU A 586
LEU A 561
LEU A 429
LEU A 655
ALA A 554
None
1.16A 4p65B-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65G-2b8eA:
undetectable
4p65H-2b8eA:
undetectable
4p65B-2b8eA:
8.13
4p65D-2b8eA:
8.13
4p65G-2b8eA:
8.70
4p65H-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_G_IPHG101_0
(INSULIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 11 LEU A 586
VAL A 421
LEU A 561
LEU A 429
ALA A 554
None
1.00A 4p65B-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65G-2b8eA:
undetectable
4p65H-2b8eA:
undetectable
4p65B-2b8eA:
8.13
4p65D-2b8eA:
8.13
4p65G-2b8eA:
8.70
4p65H-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_I_IPHI101_0
(INSULIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 VAL A 421
LEU A 561
LEU A 586
LEU A 429
ALA A 554
None
0.94A 4p65B-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65I-2b8eA:
undetectable
4p65J-2b8eA:
undetectable
4p65B-2b8eA:
8.13
4p65D-2b8eA:
8.13
4p65I-2b8eA:
8.70
4p65J-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_K_IPHK101_0
(INSULIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A 586
VAL A 421
LEU A 561
LEU A 429
ALA A 554
None
1.00A 4p65F-2b8eA:
undetectable
4p65H-2b8eA:
undetectable
4p65K-2b8eA:
undetectable
4p65L-2b8eA:
undetectable
4p65F-2b8eA:
8.13
4p65H-2b8eA:
8.13
4p65K-2b8eA:
8.70
4p65L-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V1F_B_BQ1B1087_0
(F0F1 ATP SYNTHASE
SUBUNIT C)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 8 ALA A 531
ALA A 545
ILE A 543
ALA A 454
LEU A 449
None
1.44A 4v1fA-2b8eA:
undetectable
4v1fB-2b8eA:
undetectable
4v1fA-2b8eA:
16.91
4v1fB-2b8eA:
16.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JL7_A_ASDA601_1
(AROMATASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 10 ILE A 571
ASP A 424
THR A 428
VAL A 635
LEU A 626
None
1.35A 5jl7A-2b8eA:
0.0
5jl7A-2b8eA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JL9_A_ASDA601_1
(AROMATASE)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 9 ILE A 571
ASP A 424
THR A 428
VAL A 635
LEU A 626
None
1.35A 5jl9A-2b8eA:
0.0
5jl9A-2b8eA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB5_A_NMYA301_0
(AAC(3)-IIIB PROTEIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 11 ASP A 622
ASP A 574
THR A 572
THR A 428
GLY A 427
None
1.34A 6mb5A-2b8eA:
undetectable
6mb5A-2b8eA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_C_NMYC302_0
(AAC(3)-IIIB PROTEIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 10 ASP A 622
ASP A 574
THR A 572
THR A 428
GLY A 427
None
1.34A 6mb9C-2b8eA:
0.0
6mb9C-2b8eA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_D_NMYD302_0
(AAC(3)-IIIB PROTEIN)
2b8e CATION-TRANSPORTING
ATPASE

(Archaeoglobus
fulgidus)
5 / 10 ASP A 622
ASP A 574
THR A 572
THR A 428
GLY A 427
None
1.35A 6mb9D-2b8eA:
undetectable
6mb9D-2b8eA:
16.47